These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11094416)

  • 21. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologics - beyond the joints.
    Szekanecz Z; Szántó S; Szabó Z; Váncsa A; Szamosi S; Bodnár N; Szücs G
    Autoimmun Rev; 2010 Oct; 9(12):820-4. PubMed ID: 20667515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
    Tanaka Y
    Nihon Rinsho; 2006 Dec; 64(12):2359-66. PubMed ID: 17154104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
    Di Munno O; Delle Sedie A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
    Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis.
    Ji JD; Woo JH; Choi SJ; Lee YH; Song GG
    Med Hypotheses; 2009 Aug; 73(2):201-2. PubMed ID: 19349124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory mediators as essential elements in bone remodeling.
    Goldring SR
    Calcif Tissue Int; 2003 Aug; 73(2):97-100. PubMed ID: 14565589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
    Jochems C; Islander U; Erlandsson M; Verdrengh M; Ohlsson C; Carlsten H
    Arthritis Res Ther; 2005; 7(4):R837-43. PubMed ID: 15987485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone loss in osteoporosis and arthritis. Pathogenesis and therapeutic strategies.
    Albogami MM; Jawad AS; Mageed RA
    Saudi Med J; 2014 Mar; 35(3):224-33. PubMed ID: 24623201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis.
    Tan AL; Tanner SF; Conaghan PG; Radjenovic A; O'Connor P; Brown AK; Emery P; McGonagle D
    Arthritis Rheum; 2003 May; 48(5):1214-22. PubMed ID: 12746894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.
    Gough A; Sambrook P; Devlin J; Huissoon A; Njeh C; Robbins S; Nguyen T; Emery P
    J Rheumatol; 1998 Jul; 25(7):1282-9. PubMed ID: 9676757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates.
    Romas E
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1065-79. PubMed ID: 16301197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone remodelling in inflammatory arthritis.
    Goldring SR; Purdue PE; Crotti TN; Shen Z; Flannery MR; Binder NB; Ross FP; McHugh KP
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii52-5. PubMed ID: 23253928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
    Sambrook P; Birmingham J; Champion D; Kelly P; Kempler S; Freund J; Eisman J
    J Rheumatol; 1992 Mar; 19(3):357-61. PubMed ID: 1533677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of rheumatoid arthritis on bone.
    Haugeberg G; Ørstavik RE; Kvien TK
    Curr Opin Rheumatol; 2003 Jul; 15(4):469-75. PubMed ID: 12819477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone loss in rheumatoid arthritis: systemic, periarticular, and focal.
    Deal C
    Curr Rheumatol Rep; 2012 Jun; 14(3):231-7. PubMed ID: 22527950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Rheumatoid Arthritis on Bone Loss: Links to Osteoporosis and Osteopenia.
    Kareem R; Botleroo RA; Bhandari R; Ogeyingbo OD; Ahmed R; Gyawali M; Venkatesan N; Elshaikh AO
    Cureus; 2021 Aug; 13(8):e17519. PubMed ID: 34603889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common mechanisms and holistic care in atherosclerosis and osteoporosis.
    Szekanecz Z; Raterman HG; Pethő Z; Lems WF
    Arthritis Res Ther; 2019 Jan; 21(1):15. PubMed ID: 30630495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Joint appendages: the structures which have historically been overlooked in arthritis research and therapy development.
    Ash Z; McGonagle D
    Best Pract Res Clin Rheumatol; 2011 Dec; 25(6):779-84. PubMed ID: 22265260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of a water-soluble fraction of bone marrow with malic acid in diseases of the joints].
    ARCIELLO G; MAZZELLA DI BOSCO M
    Riforma Med; 1951 Aug; 65(32):880-1. PubMed ID: 14900798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.